Research suggests that corn silk and its bioactive constituents, including flavonoids like maysin and polysaccharides, may have blood sugar-regulating properties, with studies pointing to potential reductions in blood glucose levels, improved insulin sensitivity, and favorable changes in lipid markers. The available evidence comes from two narrative reviews and two preclinical animal and cell-based studies, all of which point in a supportive direction, though no randomized controlled trials or human clinical studies are represented in this body of research. Studies indicate that specific compounds found in corn silk may work through mechanisms involving fat cell development, antioxidant activity, and glucose metabolism, but these findings have been observed in mice and laboratory cell cultures, which do not reliably predict how the same effects would play out in people. The overall picture is preliminary and promising rather than conclusive, and further research including well-designed human trials would be needed before strong conclusions can be drawn about corn silk's role in blood sugar regulation.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| An Umbrella Insight into the Phytochemistry Features and Biological Activitie... | Review | 2024 | Supports | 72 |
| Corn silk maysin ameliorates obesity in vitro and in vivo via suppression of ... | Other | 2017 | Supports | 67 |
| Research on the Mechanism and Material Basis of Corn (Zea mays L.) Waste Regu... | Review | 2024 | Supports | 62 |
| Physicochemical properties and antidiabetic effects of a polysaccharide from ... | Other | 2017 | Supports | 57 |